The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a randomized controlled trial

Keyphrases

• Randomized Controlled Trial 100%
• Postmenopausal Osteoporosis 100%
• Teriparatide 100%
• Parathyroid Hormone (1-34) 100%
• Whole-body Vibration Training 100%
• Treatment Effect 25%
• Bone Mineral Density 25%
• Bone Turnover Markers 18%
• Bone Microarchitecture 18%
• Beneficial Effects 12%
• Lumbar Bone Mineral Density 12%
• Exercise Group 12%
• Sclerostin 12%
• No Significant Difference 6%
• Lumbar Spine 6%
• Hip Bone 6%
• Clinically Significant 6%
• Intention-to-treat Analysis 6%
• Between-group 6%
• Osteoporosis 6%
• Group by 6%
• Muscle Strength 6%
• Intact Parathyroid Hormone (iPTH) 6%
• Mechanical Loading 6%
• Anabolic Therapy 6%
• Parathyroid Hormone Analogs 6%
• Bone Strength 6%
• Animal Data 6%
• Increased Effect 6%
• Linear Mixed-effects Regression Model 6%

Biochemistry, Genetics and Molecular Biology

• Parathyroid Hormone 100%
• Randomized Controlled Trial 100%
• Whole Body Vibration 100%
• Bone Density 54%
• Bone Turnover 27%
• Sclerostin 18%
• Muscle Strength 9%
• Postmenopause 9%
• Bone Strength 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Postmenopause Osteoporosis 100%
• Parathyroid hormone[1-34] 100%
• Sclerostin 11%
• Parathyroid Hormone 5%
• Parathyroid Hormone Derivative 5%